Viatris (VTRS) Revenue (2019 - 2026)
Viatris (VTRS) posted Revenue of $3.8 billion for Q2 2026, up 6.82% on a QoQ basis from $3.5 billion in Q1 2026, and up 4.88% year-over-year from $3.6 billion in Q2 2025.
Analysis
Viatris (VTRS) Revenue (2019 - 2026) Analysis & Trends
Viatris has reported Revenue for 8 years, with the latest figure at $3.8 billion in Q2 2026.
- On a quarterly basis, Revenue rose 4.88% year-over-year to $3.8 billion in Q2 2026; TTM through Jun 2026 was $14.7 billion, a 4.4% increase from a year earlier, with the FY2025 full-year figure at $14.3 billion, down 2.98% from the prior year.
- Revenue was $3.8 billion for Q2 2026 at Viatris, up from $3.5 billion in the prior quarter.
- The five-year high for Revenue was $4.2 billion in Q1 2022, with the low at $3.3 billion in Q1 2025.
- Average Revenue over 5 years is $3.8 billion, with a median of $3.8 billion recorded in 2025.
- The sharpest annual moves came in 2025 and 2026: Revenue decreased 11.17% in 2025, then grew 8.07% in 2026.
- Over 5 years, Revenue stood at $3.9 billion in 2022, then declined by 1.0% to $3.8 billion in 2023, then slipped by 8.06% to $3.5 billion in 2024, then climbed by 4.97% to $3.7 billion in 2025, then increased by 1.44% to $3.8 billion in 2026.
- The last three Revenue figures came in at $3.8 billion (Q2 2026), $3.5 billion (Q1 2026), and $3.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.90 Bn | 39.24 Bn | 2.15 Bn | 4.14 Bn |
| 2 | Viatris | 19.25 Bn | 18.36 Bn | 1.46 Bn | 3.76 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 852.47 Mn |
| 4 | Amneal Pharmaceuticals | 5.52 Bn | 5.39 Bn | 334.51 Mn | 796.20 Mn |
| 5 | Bausch Health Companies | 2.38 Bn | 537.63 Mn | 2.10 Bn | 2.85 Bn |
| 6 | Alvotech | 1.49 Bn | 1.35 Bn | 2.56 Mn | 54.76 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 266.04 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 183.90 Mn |
| 9 | Fennec Pharmaceuticals | 410.05 Mn | 368.80 Mn | 17.15 Mn | 17.87 Mn |
| 10 | RedHill Biopharma | 179.93 Mn | 179.93 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.76 Bn |
| Mar 31, 2026 | 3.52 Bn |
| Dec 31, 2025 | 3.70 Bn |
| Sep 30, 2025 | 3.76 Bn |
| Jun 30, 2025 | 3.58 Bn |
| Mar 31, 2025 | 3.25 Bn |
| Dec 31, 2024 | 3.53 Bn |
| Sep 30, 2024 | 3.75 Bn |
| Jun 30, 2024 | 3.80 Bn |
| Mar 31, 2024 | 3.66 Bn |
| Dec 31, 2023 | 3.84 Bn |
| Sep 30, 2023 | 3.94 Bn |
| Jun 30, 2023 | 3.92 Bn |
| Mar 31, 2023 | 3.73 Bn |
| Dec 31, 2022 | 3.88 Bn |
| Sep 30, 2022 | 4.08 Bn |
| Jun 30, 2022 | 4.12 Bn |
| Mar 31, 2022 | 4.19 Bn |
| Dec 31, 2021 | 4.34 Bn |
| Sep 30, 2021 | 4.54 Bn |